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IN animal models, immune activation is often difficult
to assess because of the limited availability of specific
assays to detect cytokine activities. In human mono-
cytes/macrophages,  interferon-g induces  increased
production of neopterin and an enhanced activity of
indoleamine 2,3-dioxygenase, which degrades trypto-
phan via the kynurenine pathway. Therefore, mon-
itoring  of  neopterin  concentrations  and  of  trypto-
phan degradation can serve to detect the extent of T
helper cell 1-type immune activation during cellular
immune response in humans. In a porcine model of
cardiac  arrest,  we  examined  the  potential  use  of
neopterin  measurements  and  determination  of  the
tryptophan degradation rate as a means of estimating
the extent of immune activation. Urinary neopterin
concentrations  were  measured  with  high-perform-
ance liquid chromatography (HPLC) and radioimmu-
noassay  (RIA)  (BRAHMS  Diagnostica,  Berlin,  Ger-
many).  Serum  and  plasma  tryptophan  and
kynurenine  concentrations  were  also  determined
using HPLC. Serum  and urine neopterin concentra-
tions were not detectable with HPLC in these speci-
mens, whereas RIA gave weakly (presumably  false)
positive results. The mean serum tryptophan concen-
tration was 39.0  ±  6.2 m mol/l, and the  mean kynur-
enine  concentration  was  0.85  ±   0.33 m mol/l.  The
average  kynurenine-per-tryptophan  quotient  in
serum was 21.7 ±  8.4nmol/m mol, and that in plasma
was 20.7 ±  9.5nmol/m mol (n = 7), which corresponds
well to normal values in humans. This study provides
preliminary data to support the monitoring of trypto-
phan degradation but not neopterin concentrations
as a potential means of detecting immune activation
in a porcine model. The kynurenine-per-tryptophan
quotient may serve as a short-term measurement of
immune activation and hence permit an estimate of
the extent of immune activation.
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Introduction
In animal models, immune activation is often difficult
to assess because of the limited availability of (spe-
cies-)specific  assays  to  detect  cytokine  activities.
Moreover,  the  biologic  half-life  of cytokines is  low,
and  they  may  rapidly  bind  to  target  cells  or  be
inactivated  by,  for  example,  soluble  receptors,
thereby escaping measurement. In humans, measure-
ment  of  neopterin  in  serum  or  urine  has  been
established  as  a  sensitive  marker  of  cellular,  i.e. T
helper cell 1-type, immune response.1 Neopterin is a
stable, low-molecular mass compound (253Da) pro-
duced  in  increased  concentrations  by  interferon
(IFN)-g-stimulated  human  and  primate  monocytes/
macrophages. In these cells, neopterin is produced at
the  expense  of  biopterin,  because  of  a  relative
deficiency  of  6-pyruvoyltetrahydropterin  synthase
(PTPS), the  enzyme  responsible for  biosynthesis  of
5,6,7,8-tetrahydrobiopterin. In other cells, and also in
monocytes/macrophages of other species, PTPS activ-
ity  is  constitutively  high,  and  no  or  very  low
concentrations of  neopterin  can  be  detected.2 The
clinical use of neopterin determination ranges from
surveillance of allograft recipients for early detection
of immunological complications in order to predict
prognosis, to control of therapy in malignant diseases
and HIV infection.1,3
IFN-g also stimulates indoleamine 2,3-dioxygenase
(IDO),  an  enzyme  degrading  free  tryptophan  in  a
broad variety of cells including macrophages to form
N-formylkynurenine, which is subsequently deformy-
lated to kynurenine.4 Thus, the simultaneous determi-
nation of kynurenine and tryptophan in serum and
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tient provide an estimate of IDO activity, and hence of
endogenous  formation of  IFN-g.5,6 In conditions of
cellular immune activation in humans, a correlation
exists between serum neopterin concentrations and
the kynurenine-per-tryptophan quotient.5,7
In animal model systems, except simian, neopterin
measurements have not been considered an appro-
priate  means  of  assessing immune  activation status
because previous trials to determine neopterin con-
centrations in animals mostly revealed concentrations
below the detection limit of available assay systems.8
With the improvement of analytical methods over the
past  15  years, however,  the sensitivity  of  assays to
detect neopterin in body fluids has been significantly
enhanced.
In  a  porcine  model  of  cardiac  arrest,  we  re-
examined  the  potential  use  of  neopterin  measure-
ments  and  the  determination  of  the  tryptophan




This study was performed according to Utstein-style
guidelines9 in seven healthy, 18- to 20-week-old swine
weighing 61 ± 8kg.
Surgical preparation and experiment protocol
Instrumentation, pre-medication and anesthesia were
performed  as  described  elsewhere.10–12 In  brief,  a
saline-filled catheter was advanced into the abdominal
aorta to measure aortic blood pressure and take blood
samples. Fifteen minutes before cardiac arrest, 5000U
of  heparin  were  administered intravenously to  pre-
vent intracardiac clot formation. Instead of external
manual chest compression, a heart–lung machine was
used to control the blood flow in  this reanimation
model. Three episodes of cardiac arrest were induced
by a 50-Hz, 60-V alternating current applied via two
subcutaneous needle electrodes, and ventilation was
discontinued at that point. After a period of cardiac
arrest (4min in episode 1; 8min in episodes 2 and 3),
a  reduced  blood  flow  (10%  of  normal  blood  flow
during episode 1; 20% of normal blood flow during
episodes 2  and 3)  was supplied  by  the heart–lung
machine.  The  total  duration  of  the  episodes  was
22min (episode 1) and 10–14min (episodes 2 and 3).
After each episode, an attempt was made to defibril-
late the pigs. If electric defibrillation was not success-
ful,  sinus  rhythm  was  restored  by  providing  60%
blood flow via the heart–lung machine. Between the
cardiac  arrest  episodes,  the  pigs  were  given  a
recovery  phase  of  1h.  The  total  duration  of  the
experiment was 5h.
Measurements
Blood samples were collected from a catheter in the
arteria femoralis immediately after instrumentation to
obtain  baseline  values.  Further  specimens  were
drawn before starting each episode and at the end of
the experiment before necropsy. Blood samples were
placed  in  serum  monovettes  or  heparinized  blood
monovettes and centrifuged at 1500 ´ g for 10min at
4°C.  The  supernatant,  i.e.  plasma  or  serum,  was
stored at –20°C until  measurement. Urine was col-
lected immediately after instrumentation and stored
at 4°C for a maximum of 2 days.
Urinary neopterin concentrations were measured
with  high-performance  liquid  chromatography
(HPLC)13 and  radioimmunoassay  (RIA),  permitting
detection of 0.2nmol/l neopterin (BRAHMS Diagno-
stica, Berlin, Germany). Concentrations were divided
by  urinary  creatinine  concentrations,  which  were
simultaneously  determined using  HPLC, to  account
for differences in urine densities. Serum and plasma
tryptophan  and  kynurenine  concentrations  were
determined with HPLC.6 The method was modified
slightly:  a  LiChroCART™  55–4  RP18  column
(MERCK,  Darmstadt,  Germany)  was  used,  which
reduced analysis time to 7min while ensuring suffi-
cient analytical performance.
Statistics
The data are reported as Mean ± SD. Comparison of
different groups is performed using analysis of vari-
ance. We  considered  two-tailed  p<0.05  statistically
significant.
Admission
This  project was  approved by  the Austrian  Federal
Animal Investigation Committee, and the pigs were
managed  in  accordance with  the American  Physio-
logical Society and institutional guidelines.
Results
Mean urinary neopterin concentration (± SD) was 9.5
±  5.0nmol/l  (range,  3.4  –  17.1nmol/l;  n =  7)  as
measured  by  RIA.  However,  the  results  were  not
confirmed  by  HPLC,  having  a  detection  limit  of
1.0nmol/l. Neopterin concentrations in all the urine
specimens  were  below  this  limit.  Serum  neopterin
concentrations were <0.2nmol/l in all serum/plasma
specimens and hence below the detection limit of the
RIA. The mean serum tryptophan concentration was
39.0 ± 6.2mmol/l, and the mean kynurenine concen-
tration was 0.85  ±  0.33mmol/l. The average kynur-
enine-per-tryptophan quotient in serum was 21.7  ±
8.4nmol/mmol  and  that  in  plasma  was  20.7  ±
9.5nmol/mmol  (n =  7). The  kynurenine-per-trypto-
A. Amann et al.
344 Mediators of Inflammation · Vol 10 · 2001phan  quotients  in  serum  and  plasma  were  linearly
correlated (r = 0.94; p = 0.0016; n = 7), and there
existed  an  inverse  relationship  between  the  kynur-
enine-per-tryptophan quotients and the urine neop-
terin concentrations measured by RIA (r =  –0.819,
p<0.001; Fig. 1).
Fig. 2 shows the development of the kynurenine-
per-tryptophan quotient in serum between baseline
values  and  the  values  obtained  at  the  end  of  the
reanimation experiment. In female pigs, the quotient
increased (p<0.05; n = 4), whereas no such difference
was seen in male pigs (p = 0.66; n = 3).
Discussion
Increased neopterin concentrations and an enhanced
tryptophan degradation rate reflect the extent of T
helper cell 1-type immune activation during cellular
immune  response  in  humans.  This  study  provides
preliminary data in  support of  the potential use  of
tryptophan degradation but not neopterin concentra-
tions  as  immune  activation  markers  in  a  porcine
model.  Urinary  concentrations of  neopterin  in  the
non-primate animals were detected by RIA, and the
baseline magnitude of measured neopterin concentra-
tions lies well within a range accessible with standard
analytical methods like immunoassays or HPLC. How-
ever,  HPLC  measurements  could  not  confirm  the
results obtained with RIA. An analytical uncertainty is
the possible cross-reaction of the assay antibody with
dihydroforms of neopterin and with biopterin deriva-
tives,14 other  pteridines  that  are  excreted  via  the
kidneys in considerable amounts. It thus seems very
likely that the neopterin concentrations measured by
means of RIA in the porcine model are biased by a
possible cross-reaction. Further studies are necessary
to clarify this issue. In addition, an inverse relation-
ship was found between the kynurenine-per-trypto-
phan  quotients  and  the  neopterin  concentrations
measured  by  RIA.  Previous  studies  conducted  in
humans commonly showed a positive relationship,5–7
which  agrees  with  the  background  common  for
tryptophan  degradation  and  neopterin  production,
both of which are induced by cytokine IFN-g. Thus,
the neopterin concentrations detected with RIA are
highly  questionable.  Serum  or  plasma  neopterin
concentrations were all <0.2nM, which is still below
the detection limit of the available immunoassay.
More  relevant  information  about  immune  activa-
tion status was gained from the tryptophan degrada-
tion rate in serum. Baseline values of the kynurenine-
per-tryptophan  quotient  in  pigs  approximately
correspond  to  values  in  humans,5,6 and  serum  or
plasma specimens are equally suited for HPLC meas-
urement  of  tryptophan  and  kynurenine.  After  the
experiment,  an  increase  was  seen  in  the  quotient,
which also lies in the range of human values during
infectious or inflammatory disorders.5 The increased
degradation  of  tryptophan  during  the  reanimation
experiment was apparent only in female pigs, which
could be attributed to the small number of animals
tested. On the contrary, hormonal differences could
also play a role; for example, estradiol was found to
affect tryptophan metabolism in rat liver.15
The kynurenine-per-tryptophan quotient may ena-
ble  short-term  measurement  of  immune  activation
and  thus  an  estimate  of  the  extent  of  immune
activation in porcine animal models (e.g. ischemia/
reperfusion experiments, cardiac arrest, hypovolemia
or  endotoxic  shock  syndrome).  When  tryptophan
catabolism in  pigs  is analogously  controlled like  in
humans, high values can be expected in, for example,
an endotoxic shock model.
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FIG. 1. Kynurenine-per-tryptophan (kyn/trp) quotients meas-
ured in  serum  versus  concentration  of  neopterin in urine
(baseline values).
FIG. 2. Kynurenine-per-tryptophan (kyn/trp) quotients meas-
ured in serum for baseline and at the end of the reanimation
experiment (male (x) and female (o) animals).References
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